What is female sexual dysfunction? +Sexual Health in Faith Traditions (SHIFT) Study +Sexual Health Rankings +Sexual Health Research Network +Sexual Health Visual
A woman’s sexual
responsiveness is not the same as a man’s.
Ignoring its complexity can make difference
look like dysfunction.
The more things change, the
more they remain the same. Just when it began
to seem as though gender-specific medicine
was here to stay, medical research in males
is once again being applied to women. The success
of sildenafil (Viagra) in treating erectile
dysfunction in men has spawned a spate of studies
of that drug in women, which have shown little
promise. It has also given rise to a movement
to establish female sexual dysfunction (FSD)
as a new disease category, just as erectile
dysfunction had been in the 1990s.
Coming
up with a definition
The implied parallel between
FSD and male impotence is deceptive. The word “dysfunction” — medical
parlance for anything that doesn’t work
the way it should — suggests that there
is an acknowledged norm of female sexual function.
That norm has never been established. Unlike
penile erection, which is a quantifiable physical
event, a woman’s sexual response is qualitative.
It embodies desire, arousal, and gratification — and
it can’t be measured objectively. Without
an empirical standard by which to assess female
sexual function, it would seem difficult, if
not impossible, to come up with criteria for
female sexual dysfunction.
That hasn’t stopped
experts from trying. The American Foundation
for Urologic Disease has held yearly international
consensus conferences on FSD. The goal has
been to mirror the work of a National Institutes
of Health panel that developed diagnostic and
treatment guidelines for erectile dysfunction.
In doing so, the FSD panel built on definitions
of sexual dysfunction from the World Health
Organization’s International Classification
of Diseases (ICD-10) and the American Psychiatric
Association’s Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV). The
ICD-10 focuses on physical factors that influence
sexual response, and the DSM-IV emphasizes
the emotional and psychological factors involved.
Although neither publication defines female sexual
dysfunction as such, both have subsets of the
sexual dysfunction category that apply exclusively
to women.
The FSD panel’s first
report, which was published in the March 2000
issue of the Journal of Urology, proposed
a working definition of sexual dysfunction
in women that includes both physiological and
psychological symptoms. Experiencing any one
of them warrants an FSD diagnosis, but some
must also be a source of distress for the woman
to qualify as a sign of FSD.
Definitions of female sexual dysfunction (FSD) |
|
Disorder | Description |
Hypoactive sexual desire disorder† | Chronic lack of interest in sexual activity |
Sexual aversion disorder† | Persistent or recurrent phobic avoidance of sexual contact with a partner |
Sexual arousal disorder† | Persistent or recurrent inability to attain or maintain sexual excitement |
Orgasmic disorder† | Chronic difficulty in attaining (or inability to attain) orgasm following sufficient arousal |
Dyspareunia | Pain during intercourse |
Vaginismus | Involuntary vaginal spasms that interfere with penetration |
Noncoital sexual pain | Genital pain following stimulation during foreplay |
† These
must cause the woman distress in order
to qualify as FSD. Source: Basson R, et al. “Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications,” Journal of Urology (March 2000), 163:888–895. |
Is
there an epidemic?
Viagra alone didn’t
spark this interest in FSD. It can also be
attributed to the publication of a 1999 study
indicating that 43% of American women experienced
sexual dysfunction (Journal of the American
Medical Association, Feb. 10, 1999).
That simple number, which
has become the mantra of FSD advocates, belies
the complexity of the issue. The 43% figure
emerged from an analysis of responses by 1,749
women and 1,410 men to a similar set of questions.
Women who reported any of the following — lack
of sexual desire, difficulty in becoming aroused,
inability to achieve orgasm, anxiety about
sexual performance, reaching orgasm too rapidly,
pain during intercourse, or failure to derive
pleasure from sex — were conside red
to have sexual dysfunction. Women were more
likely to suffer from sexual dysfunction if
they were single, had less education, had physical
or mental health problems, had undergone recent
social or economic setbacks, or were dissatisfied
with their relationship with a sexual partner.
In the years since the report’s
publication, researchers have revisited it
and challenged its conclusions. Several critics
have pointed out that the women were not asked
whether their problems were severe enough to
cause personal distress. Some have also noted
that the duration of problems in the survey — two
months — may have represented only a
temporary response to illness or other stress.
In 2000, critics garnered
additional support from a preliminary report
by the Kinsey Institute, the organization that
published a benchmark study on female sexual
behavior in 1953. The most recent Kinsey data
indicate that emotional health and personal
relationship factors were more important for
women’s sexual satisfaction than achieving
orgasm. In that survey, general well-being
ranked at the top as a requirement, followed
by emotional reactions during lovemaking, the
attractiveness of one’s partner, physical
response to lovemaking, frequency of sexual
activity with one’s partner, the partner’s
sensitivity, one’s own state of health,
and the partner’s state of health.
Women and men are different
In an article published in
the October 2002 issue of the Archives of
Sexual Behavior, Dr. John Bancroft, director
of the Kinsey Institute, suggested several
reasons why women and men have evolved to experience
their sexuality differently. First, although
testosterone stimulates the libido in both
sexes, it’s a far stronger determinant
of sexual interest in men. Second, male orgasm
(ejaculation) is essential for reproduction,
while female orgasm is — in strictly
reproductive terms — irrelevant.
Bancroft also speculated
that women’s greater tendency toward
sexual inhibition could be a response to cultural
influences. Most societies have restricted
women’s sexual expression more tightly
than men’s. According to Bancroft, sexual
inhibition might also be a protective mechanism
evolved to discourage women from having more
children than they can raise — a danger
when, for example, a partner is unsupportive
or the woman has physical or emotional problems.
The woman is “turned off” because,
in an evolutionary sense, the conditions for
motherhood aren’t favorable. If this
theory is correct, some women whose sexual
response has been deemed dysfunctional might
actually be functioning as nature intended.
Despite the annual consensus
conferences on FSD, both the term and the suggested
diagnostic criteria continue to be widely debated.
But there is one aspect of the suggested guidelines
that no one is disputing — the stipulation
that problems with sexual arousal must be “a
source of distress” to the woman. If
you’re satisfied with your sex life,
you don’t have FSD.
There’s little doubt
that Viagra’s influence has spilled over
into the arena of women’s health. By
kindling a search for a comparable elixir to
treat women’s sexual problems, Viagra
has made women’s sexuality a high-profile
research target. And by enabling older men
to recover erectile function, it has stimulated
research into later-life sex and drawn welcome
attention to the sexual vitality of postmenopausal
women.
But the resulting focus on
pharmaceutical rather than emotional solutions
has serious limitations. This way of framing
the problem threatens to make women’s
sexual experience, no less than men’s,
a performance issue. Also, without downplaying
the significance of any woman’s pain
or distress, there can be real danger in defining difference as “dysfunction.”
Although the incidence of
sexual dysfunction may have been exaggerated,
the problem is real for millions of women.
It’s rarely a simple issue, because sexual
pleasure — and sexual distress — involve
a complex web of physical and emotional factors.
If you’re dissatisfied with your sex
life, you may want to try any or all of the
following:
Have an honest discussion
with your partner. Sexual pleasure
is the result of a mind/body collaboration — usually
involving two minds and two bodies. As
surveys attest, the most satisfying sexual
activity is the product of a caring, secure
personal relationship. When one partner
is dysfunctional, the other is affected
as well. For example, a woman may interpret
her partner’s inability to have an
erection as a sign that he no longer finds
her attractive. A talk with one’s
partner can help to determine whether the
problem is primarily physical or emotional.
Seek medical treatment. If
sexual problems are new — especially
if you’re postmenopausal, have undergone
surgery, have developed a chronic medical condition,
or are taking a new medication — you
should discuss the circumstances with your
doctor. A variety of physical changes can be
responsible for discomfort or reduced pleasure
during sex (see chart), and many can be reversed
with appropriate therapy.
Conditions, procedures, and drugs that can affect sexual response in women |
|
Condition | Effect(s) |
Estrogen insufficiency | Reduced vaginal lubrication |
Testosterone insufficiency | Reduced libido |
Diabetes | Reduced vaginal lubrication, vaginal infections |
Thyroid, adrenal, pituitary disorders | Reduced vaginal lubrication |
Sickle cell anemia | Decreased arousal and orgasm |
Spinal cord damage, stroke, Parkinson’s disease, multiple sclerosis | Decreased vaginal lubrication, arousal, orgasm |
Vaginitis, pelvic inflammatory disease, endometriosis | Vaginismus, dyspareunia |
Prolapsed uterus or uterine fibroids | Decreased arousal |
Kidney failure requiring dialysis | Decreased arousal and desire due to hormone imbalance |
Arthritis | Chronic pain that limits motion |
Sjögren’s syndrome | Decreased lubrication |
Procedure | Effect(s) |
Oophorectomy | Decreased estrogen and lubrication |
Episiotomy | Tightness of vaginal opening |
Mastectomy, colostomy | Loss of self-esteem and sources of stimulation; fear of discomfort |
Drugs | Effect(s) |
Antihypertensives (diuretics, beta blockers, calcium-channel blockers, anti-adrenergics) | Reduced libido, difficulty reaching orgasm |
Anticholinergics (propantheline, methantheline) | Decreased lubrication |
Barbiturates | Various problems at high doses |
Benzodiazepines (diazepam, alprazolam) | Difficulty reaching orgasm |
Antidepressants | Difficulty reaching orgasm |
Cancer chemotherapy (cyclophosphamide, anti-estrogens) | Vaginal dryness, reduced libido, difficulty reaching orgasm |
Opiates (morphine, codeine, methadone) | Reduced libido |
Sources: Carlson K, et al. Harvard Guide to Women’s Health; Lightner D. Mayo Clinic Proceedings, 2002 77: 698–702 |
Consider psychotherapy. Althoug
h current research, which is heavily financed
by pharmaceutical companies, emphasizes the
physical causes of sexual dissatisfaction,
surveys continue to support the old adage, “A
woman’s most important sex organ is her
brain.” Our sexual responsiveness is
strongly related to our emotional well-being,
so deep-seated issues of control and trust,
as well as identity and body image, can’t
help but influence our sexual responsiveness.
If you sense that such issues are interfering
with your sex life, you might consider psychotherapy.